Watson S P, Poole A, Asselin J
Department of Pharmacology, University of Oxford, UK.
Mol Pharmacol. 1995 Apr;47(4):823-30.
In the present study, the roles of Ca2+ and fibrinogen receptor occupancy in the regulation of phospholipase C by G protein-coupled and tyrosine kinase-linked receptor pathways in human platelets have been investigated. Agonist stimulation of phospholipase C was not altered significantly in the absence of stirring or in the presence of the fibrinogen receptor antagonist arginine-glycine-aspartate-serine, conditions that prevent platelet aggregation. Similarly, elevation of intracellular Ca2+ levels by the ionophores A23187 or ionomycin did not induce formation of inositol phosphates. In contrast, chelation of extracellular Ca2+ by ethylene glycol bis(beta-aminoethyl ether)-N,N,N',N'-tetraacetic acid (EGTA) reduced formation of inositol phosphates by G protein receptor (thrombin)- and tyrosine kinase (Fc receptor and peroxovanadate)-regulated pathways. Similarly, short term exposure to Ni2+ ions, which also prevent Ca2+ entry, inhibited thrombin-stimulated formation of inositol phosphates. Loading of platelets with the intracellular Ca2+ chelator 1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid (BAPTA) markedly suppressed elevation of intracellular Ca2+ and formation of inositol phosphates in platelets stimulated by G protein receptor- and tyrosine kinase-regulated pathways. The greater inhibition of phospholipase C by BAPTA, relative to that induced by EGTA, is consistent with the more pronounced inhibition of intracellular Ca2+ elevation. The tyrphostin tyrosine kinase inhibitor ST271 also reduced intracellular Ca2+ levels and inhibited activation of phospholipase C. The degree of inhibition of phospholipase C by ST271 was slightly greater than that induced by EGTA but was not additive with the effect of EGTA, suggesting a common mode of action. It is concluded that elevation of intracellular Ca2+ regulates agonist-induced activation of phospholipase C and that this contributes to the inhibition of thrombin-induced formation of inositol phosphates by the tyrphostin ST271.
在本研究中,已对钙离子(Ca2+)和纤维蛋白原受体占有率在人血小板中通过G蛋白偶联受体途径和酪氨酸激酶连接受体途径对磷脂酶C的调节作用进行了研究。在不搅拌或存在纤维蛋白原受体拮抗剂精氨酸 - 甘氨酸 - 天冬氨酸 - 丝氨酸的情况下,激动剂对磷脂酶C的刺激没有显著改变,这些条件可防止血小板聚集。同样,离子载体A23187或离子霉素使细胞内Ca2+水平升高也未诱导肌醇磷酸的形成。相比之下,乙二醇双(β - 氨基乙基醚)-N,N,N',N'-四乙酸(EGTA)螯合细胞外Ca2+会减少G蛋白受体(凝血酶)和酪氨酸激酶(Fc受体和过氧钒酸盐)调节途径诱导的肌醇磷酸形成。同样,短期暴露于也能阻止Ca2+内流的Ni2+离子会抑制凝血酶刺激的肌醇磷酸形成。用细胞内Ca2+螯合剂1,2 - 双(2 - 氨基苯氧基)乙烷 - N,N,N',N'-四乙酸(BAPTA)加载血小板可显著抑制G蛋白受体和酪氨酸激酶调节途径刺激的血小板中细胞内Ca2+的升高以及肌醇磷酸的形成。相对于EGTA诱导的抑制作用,BAPTA对磷脂酶C的抑制作用更强,这与细胞内Ca2+升高受到更明显抑制是一致的。酪氨酸激酶抑制剂 tyrphostin ST271也降低了细胞内Ca2+水平并抑制了磷脂酶C的激活。ST271对磷脂酶C的抑制程度略大于EGTA诱导的抑制程度,但与EGTA的作用无相加效应,表明其作用方式相同。得出的结论是,细胞内Ca2+的升高调节激动剂诱导的磷脂酶C激活,并且这有助于酪氨酸激酶抑制剂ST271抑制凝血酶诱导的肌醇磷酸形成。